Charlotte Palmer
Oxford-BMS Postdoctoral Fellow
- Postdoctoral Researcher in Myeloma Epigenetic Target Discovery
Recent publications
-
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Journal article
Kurata K. et al, (2023), Blood cancer j, 13
-
Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.
Journal article
Kurata K. et al, (2023), Blood cancer j, 13
-
Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone Biomarkers.
Journal article
Agarwal G. et al, (2022), Cancers (basel), 15
-
Metabolic profiling of prostate cancer in skeletal microenvironments identifies G6PD as a key mediator of growth and survival.
Journal article
Whitburn J. et al, (2022), Sci adv, 8
-
Development of a mass cytometry-based toolkit to investigate myeloma therapeutic responses ex vivo
Conference paper
Gooding S. et al, (2022), Clinical lymphoma myeloma & leukemia, 22, S71 - S71